Abstract:Background: Doxorubicin (DOX) is a powerful anti-tumor anthracycline drug. However, its clinical use is limited due to the side effect of cardiotoxicity. Tanshinone I (Tan I) is one of the major tanshinones isolated from Salvia miltiorrhiza. Studies have shown that Tan I is effective in the treatment of cardiovascular diseases. However, the potential effects of Tan I against DOX-induced cardiotoxicity (DIC) have yet to be explored. Purpose: This study aimed to explore whether Tan I can protect against DIC and to reveal whether Tan I can exert anti-oxidative effect by regulating nuclear erythroid factor 2-related factor 2 (Nrf2) pathway. Methods: DIC models were established in vivo by intravenous injection of DOX. Echocardiography was used to monitor the cardiac function of mice. Transmission electron microscopy was used to assess mitochondrial damage. Oxidative stress was measured by dihydroethidium (DHE) staining and western blotting. The accumulation and nuclear translocation of Nrf2 was detected by immunofluorescence. H9C2 cellular DIC model was established in vitro to explore the pharmacological mechanism. Nrf2 small interfering (si)-RNA was applied to H9C2 cells to explore whether Tan I exerted protective effect against DIC through Nrf2 signaling pathway. The protective effects of Tan I on mitochondrial function and mitochondrial membrane permeability were measured by MitoSOX™ Red and JC-1 staining assays, respectively. Results: In vivo experiments revealed that Tan I could improve cardiac function and protect against DOX-induced myocardial structural damages in mice models. The oxidative stress induced by DOX was suppressed and apoptosis was mitigated by Tan I treatment. Tan I protected against DOX-induced mitochondrial structural damage. Meanwhile, key proteins in Nrf2 pathways were upregulated by Tan I treatment. In vitro studies showed that Tan I attenuated DOX-induced generation of reactive oxygen species (ROS) in cultured H9C2 cells, reduced apoptotic rates, protected mitochondrial functions and up-regulated Nrf2 signaling pathway. Tan I promoted accumulation and nuclear translocation of Nrf2 protein. In addition, interference of Nrf2 abrogated the anti-oxidative effects of Tan I and reversed the expressions of key proteins in Nrf2 pathway. The protective effects of Tan I on mitochondrial integrity was also mitigated by Nrf2 interference. Conclusion: Tan I could reduce oxidative stress and protect against DIC through regulating Nrf2 signaling pathway. Nrf2 is a potential target and Tan I is a novel candidate agent for the treatment of DIC.

Synthesis and biological evaluation of tanshinone IIA derivatives as novel endothelial protective agents

Tanshinone IIA Protects Against Methylglyoxal-Induced Injury in Human Brain Microvascular Endothelial Cells.

Tanshinone Iia Attenuates H2o2-Induced Injury in Human Umbilical Vein Endothelial Cells

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Tanshinone I Inhibits Oxidative Stress–Induced Cardiomyocyte Injury by Modulating Nrf2 Signaling

Synthesis of Caffeic Acid Sulfonamide Derivatives and Their Protective Effect Against H2O2 Induced Oxidative Damage in A549 Cells

Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism.

Synthesis of 13-Β-elemene Ester Derivatives and Evaluation of Their Antioxidant Activity in Human Umbilical Vein Endothelial Cells.

The Protective Effect of Tanshinone IIa on Endothelial Cells: a Generalist among Clinical Therapeutics

Mechanism of Reversal of High Glucose-Induced Endothelial Nitric Oxide Synthase Uncoupling by Tanshinone IIA in Human Endothelial Cell Line EA.hy926.

A Newly Synthesized Sinapic Acid Derivative Inhibits Endothelial Activation in Vitro and in Vivo.

Design, synthesis and biological evaluation of novel ligustrazinylated derivatives as potent cardiovascular agents

The Synthesis and Biological Evaluation of Novel Danshensu–cysteine Analog Conjugates As Cardiovascular-Protective Agents

Protective Effect of Tanshinone ⅡA on Normal and Oxidative Injured Endothelial Cells

Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis

Synthesis of Novel Caffeic Acid Derivatives and Their Protective Effect Against Hydrogen Peroxide Induced Oxidative Stress Via Nrf2 Pathway

Design, synthesis and antioxidant activity evaluation of novel β-elemene derivatives.

Tanshinone IIA attenuates TNF-α induced PTX3 expression and monocyte adhesion to endothelial cells through the p38/NF-κB pathway.

Design, synthesis and biological evaluation of marine phidianidine-inspired derivatives against oxidized ldl-induced endothelial injury by activating Nrf2 anti-oxidation pathway

Design, synthesis, and preliminary cardioprotective effect evaluation of danshensu derivatives.

Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway